MetaCap

Madrigal Pharmaceuticals Inc. Company Profile

NASDAQ: MDGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

379.10-17.64 (-4.45%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Madrigal Pharmaceuticals at a glance

Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in West Conshohocken, PA. Madrigal Pharmaceuticals is led by Mr. William J. Sibold and employs about 915 people. The company's shares have traded publicly since 2007.

At a market capitalization of $8.81 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001157601, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Madrigal Pharmaceuticals do?

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Business description based on the company's public filings.

Company information

Legal name
Madrigal Pharmaceuticals Inc.
Ticker
NASDAQ: MDGL
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. William J. Sibold
Employees
915
Headquarters
1001 Conshohocken State Road, West Conshohocken, PA, United States
Phone
267 824 2827
IPO year
2007
SEC CIK
0001157601
Latest annual report
10-K · Feb 19, 2026

Companies similar to Madrigal Pharmaceuticals

MDGL peer companies
CompanyPrice% ChgMarket capCompare
SYRESpyre Therapeutics Inc.93.47-4.26%$8.88Bvs MDGL
PRAXPraxis Precision Medicines Inc.300.43-3.37%$8.40Bvs MDGL
TGTXTG Therapeutics Inc.63.34-2.37%$9.57Bvs MDGL
SMMTSummit Therapeutics Inc.9.95-5.87%$7.96Bvs MDGL
PTGXProtagonist Therapeutics Inc.121.40-2.11%$7.92Bvs MDGL
RYTMRhythm Pharmaceuticals Inc.112.36-3.80%$7.79Bvs MDGL
ALKSAlkermes plc44.94-2.69%$7.55Bvs MDGL
KNSAKiniksa Pharmaceuticals International plc Class A93.90+0.38%$7.38Bvs MDGL

Related